Anti-RIP antibody [EPR24883-85]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
4
(1 Review)
|
(4 Publications)
Anti-RIP antibody [EPR24883-85] (ab300617) is a rabbit monoclonal antibody detecting RIP in Western Blot, IP, IHC-P. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
View Alternative Names
RIP, RIP1, RIPK1, Receptor-interacting serine/threonine-protein kinase 1, Cell death protein RIP, Receptor-interacting protein 1, RIP-1
- IHC
Supplier Data
Immunohistochemistry - Anti-RIP antibody [EPR24883-85] (AB300617)
Immunohistochemical analysis of paraffin-embedded (A) Wild-type HAP1 c tissue labeling RIP with ab300617 at 1/100 (5.11 ug/ml) followed by a LeicaDS9800 (Bond Polymer Refine Detection) was used at Ready to use dilution. Positive staining on (A) Wild-type HAP1 cell pellet(B) and no staining on RIPK1 knockout HAP1 cell pellet.The section was incubated with ab300617 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is LeicaDS9800 (Bond Polymer Refine Detection) was used at Ready to use dilution. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- IHC
Supplier Data
Immunohistochemistry - Anti-RIP antibody [EPR24883-85] (AB300617)
Immunohistochemical analysis of paraffin-embedded Human cervical carci tissue labeling RIP with ab300617 at 1/100 (5.11 ug/ml) followed by a LeicaDS9800 (Bond Polymer Refine Detection) was used at Ready to use dilution. Cytoplasmic staining on human cervical carcinoma.The section was incubated with ab300617 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is LeicaDS9800 (Bond Polymer Refine Detection) was used at Ready to use dilution. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- WB
Lab
Western blot - Anti-RIP antibody [EPR24883-85] (AB300617)
Anti-RIPK1 antibody [EPR24883-85] (ab300617) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab300617 was shown to bind specifically to RIPK1. A band was observed at 75 kDa in wild-type THP-1 cell lysates with no signal observed at this size in RIPK1 knockout cell line ab276121 (knockout cell lysate ab284221). To generate this image, wild-type and RIPK1 knockout THP-1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween$®$ 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
All lanes:
Western blot - Anti-RIP antibody [EPR24883-85] (ab300617) at 1/1000 dilution
Lane 1:
Wild-type THP-1 cell lysate at 20 µg
Lane 2:
RIPK1 knockout THP-1 cell lysate at 20 µg
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
Raji cell lysate at 20 µg
Secondary
Lanes 1 - 4:
Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Lanes 1 - 4:
Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution
Predicted band size: 75 kDa
Observed band size: 75 kDa
false
- WB
Supplier Data
Western blot - Anti-RIP antibody [EPR24883-85] (AB300617)
The expression of RIP (phospho S166) is upregulated in response to z-VAD, TNF alpha and SM-164, while it is downregulated in response to necrostain treatment (PMID : 32027418, PMID : 33273695).
The identity of the lower MW band at approximately 35 kDa is unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-RIP antibody - Total protein control (ab300617) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-RIP (phospho S166) antibody [EPR25654-166] (<a href='/en-us/products/primary-antibodies/rip-phospho-s166-antibody-epr25654-166-ab316923'>ab316923</a>) at 1/1000 dilution
Lane 1:
Untreated HT-29 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 40 µg with NFDM/TBST
Lane 2:
HT-29 treated with 20 uM z-VAD for 3.5 hours, then with 20 ng/ml TNF alpha, 100 nM SM-164 and 50 uM necrostatin added for 3 hours whole cell lysate (untreated membrane) at 40 µg with NFDM/TBST
Lane 3:
HT-29 treated with 20 uM z-VAD for 3.5 hours, then with 20 ng/ml TNF alpha and 100nM SM-164 added for 3 hours whole cell lysate (untreated membrane) at 40 µg with NFDM/TBST
Lane 4:
HT-29 treated with 20 uM z-VAD for 3.5 hours, then with 20 ng/ml TNF alpha and 100 nM SM-164 added for 3 hours whole cell lysate (Lambda phosphatase treated membrane) at 40 µg with NFDM/TBST
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 75 kDa,36 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-RIP antibody [EPR24883-85] (AB300617)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, ab316923 was shown to bind specifically to RIP. Target of interest was observed at 75 kDa in wild-type HAP1 cell lysates (lanes 1 and 3), whereas no signal observed at this size in RIP knockout cell line lysates (lanes 2 and 4).
The expression of RIP (phospho S166) is upregulated in response to z-VAD, TNF alpha and SM-164 treatment (PMID : 32027418, PMID : 33273695).
The identity of the lower MW band at approximately 15 kDa is unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-RIP antibody - Total protein control (ab300617) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-RIP (phospho S166) antibody [EPR25654-166] (<a href='/en-us/products/primary-antibodies/rip-phospho-s166-antibody-epr25654-166-ab316923'>ab316923</a>) at 1/1000 dilution
Lane 1:
Untreated wild-type HAP1(human chronic myelogenous leukemia near-haploid cell line) whole cell lysate at 50 µg
Lane 2:
Untreated RIP knockout HAP1 whole cell lysate at 50 µg
Lane 3:
Wild-type HAP1 treated with 20 uM z-VAD for 3.5 hours, then with 20 ng/ml TNF alpha and 100 nM SM-164 added for 3 hours whole cell lysate at 50 µg
Lane 4:
RIP knockout HAP1 treated with 20 uM z-VAD for 3.5 hours, then with 20 ng/ml TNF alpha and 100 nM SM-164 added for 3 hours whole cell lysate at 50 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 75 kDa,36 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-RIP antibody [EPR24883-85] (AB300617)
All lanes:
Western blot - Anti-RIP antibody [EPR24883-85] (ab300617) at 1/1000 dilution
Lane 1:
Mouse testis tissue lysate at 20 µg
Lane 2:
Rat testis tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
false
- WB
Supplier Data
Western blot - Anti-RIP antibody [EPR24883-85] (AB300617)
The identity of the lower MW band at approximately 35 kDa is unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-RIP antibody - Total protein control (ab300617) staining at 1/1000 dilution.
In Western blot, Anti-6X His tag® antibody [EPR20547] - ChIP Grade (ab213204) staining at 1/5000 dilution.
All lanes:
Western blot - Anti-RIP (phospho S166) antibody [EPR25654-166] (<a href='/en-us/products/primary-antibodies/rip-phospho-s166-antibody-epr25654-166-ab316923'>ab316923</a>) at 1/1000 dilution
Lane 1:
Untreated 293T (human embryonic kidney epithelial cell) transfected with an empty vector containing a myc-His-tag®, whole cell lysate at 20 µg with NFDM/TBST
Lane 2:
Untreated 293T transfected with a human wild-type RIP expression vector containing a myc-His-tag®, whole cell lysate at 20 µg with NFDM/TBST
Lane 3:
293T transfected with a human wild-type RIP expression vector containing a myc-His-tag® were treated with 100 nM Calyculin for 30 minutes, whole cell lysate at 20 µg with NFDM/TBST
Lane 4:
293T transfected with a human RIP (S166A mutation) expression vector containing a myc-His-tag® were treated with 100 nM Calyculin for 30 minutes, whole cell lysate at 20 µg with NFDM/TBST
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 75 kDa,36 kDa
false
Exposure time: 6s
- WB
Supplier Data
Western blot - Anti-RIP antibody [EPR24883-85] (AB300617)
All lanes:
Western blot - Anti-RIP antibody [EPR24883-85] (ab300617) at 1/1000 dilution
All lanes:
Mouse liver tissue lysate at 20 µg
Secondary
Lanes 1 - 3:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Lanes 1 - 3:
Western blot - Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/10000 dilution
false
- WB
Supplier Data
Western blot - Anti-RIP antibody [EPR24883-85] (AB300617)
All lanes:
Western blot - Anti-RIP antibody [EPR24883-85] (ab300617) at 1/1000 dilution
Lane 1:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 2:
NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 3:
PC-12 (rat adrenal gland pheochromocytoma) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
false
Related conjugates and formulations (1)
-
Anti-RIP antibody [EPR24883-85] (BSA and Azide free)
Reactivity data
Product details
What is this antibody validated in?
Anti-RIP antibody [EPR24883-85] (ab300617) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P) in Human, Mouse, Rat samples.
What is the molecular weight of RIP?
Anti-RIP [EPR24883-85] (ab300617) specifically detects a band for RIP (UniProt: Q60855) at a molecular weight of 75kDa.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-RIP antibody [EPR24883-85] (ab300617) has been confirmed by Immunohistochemistry testing in RIPK1 Knockout HAP1 cells.
Other related products
We have a range of other formats of antibody clone [EPR24883-85] also available for your convenience: ab300617, Carrier free - ab300618
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Receptor-Interacting Protein Kinase 1 (RIPK1) participates in regulating both necroptosis and apoptosis distinguishing itself as an important mediator in cell death mechanisms. As part of the necrosome complex which includes RIPK3 and MLKL RIPK1 functions in necroptosis—a programmed form of necrosis. This characteristic involvement shows its dual role in maintaining cell fate decisions making it an integral part of immune response and inflammation control.
Pathways
RIPK1 strongly associates with the TNF signaling pathway and NF-kB pathway. Its interaction with TNF receptor 1 (TNFR1) and consequent involvement with TRADD and TRAF2 mediates the signal transduction necessary for the activation of NF-kB leading to transcription of genes involved in survival and inflammation. This connection illustrates its capability to switch between promoting cell survival through NF-kB and facilitating cell death via necroptosis or apoptosis depending on cellular context and cues.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Chinese medicine 20:11 PubMed39815349
2025
Applications
Unspecified application
Species
Unspecified reactive species
In vivo (Athens, Greece) 38:1162-1169 PubMed38688607
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 22:33 PubMed38217003
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 9:109 PubMed37002200
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com